Results 161 to 170 of about 8,420 (193)

89Zr-immuno-PET

, 2019
openaire   +2 more sources

Human induced pluripotent stem cell-derived cardiomyocytes improve recovery from myocardial infarction in non-human primates. [PDF]

Stem Cell Res Ther
Guan X, Zhang P, Wang Q, Zhang Y, Zhang Y, Zhang H, Zhang H, Jiang W, Wu Y, Wang X, Wang D, Wang J, Gao L.   +12 more
europepmc   +1 more source

Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model. [PDF]

Blood Adv
Dyer MR, Zheleznyak A, Teubner EN, Prior JL, Manion B, Jing Z, Sharma AK, Du J, Tang R, Fiala MA, DiPersio JF, Veis D, O'Neal J, Berezin MY, Shokeen M.   +14 more
europepmc   +1 more source

Quantitative [⁸⁹Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI. [PDF]

J Nucl Med
Mansur A, McConathy JE, Stringer-Reasor E, Rocque G, Khoury K, Eltoum N, Nikpanah M, Bartels J, Wright B, Jahan N, Jeffers D, Lapi SE, Sorace AG.   +12 more
europepmc   +1 more source

A pair of congenic mice for imaging of transplants by positron emission tomography using anti-transferrin receptor nanobodies. [PDF]

Elife
Balligand T, Carpenet C, Olivé Palau S, Jaspers T, Suresh P, Liu X, Medhi H, Lee YH, Rashidian M, De Strooper B, Ploegh HL, Dewilde M.   +11 more
europepmc   +1 more source

Synthesis and Preclinical Development of a Novel ⁶⁸ Ga/ ⁸⁹ Zr-Labelled ανβ6-Integrin Targeting Trimer

Gariglio G, Patiño Álvarez FA, Zierke MA, Stangl S, Rheinfrank T, Holzleitner N, Kossatz S, Decristoforo C.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET

Journal of Inorganic Biochemistry, 2022
A new, bifunctional chelating ligand for immuno-Positron Emission Tomography (PET) was designed, synthesized, and conjugated to Trastuzumab for a proof-of-concept study with 89Zr. H4neunox was synthesized from the tris(2-aminoethyl)amine backbone, decorated with 8-hydroxyquinoline moieties, and utilizes a primary amine for functionalization.
Lily, Southcott, Luke, Wharton, Julie, Rousseau, Helen, Merkens, Hua, Yang, François, Bénard, Chris, Orvig   +6 more
openaire   +2 more sources

Preparation of 89Zr Solutions for Radiopharmaceuticals Synthesis

Radiochemistry, 2021
Zirconium-89 is a promising radionuclide for nuclear medicine and has optimal nuclear-physical parameters for study of processes with slow kinetic. The increasing popularity of targeted imaging has led to a concomitant development of 89Zr radiopharmaceutical chemistry.
V. B. Bubenshchikov, A. A. Larenkov, G. E. Kodina   +2 more
openaire   +1 more source

Transition rates in 89Zr

Nuclear Physics A, 1972
Abstract The lifetimes of a number of levels in 89 Zr have been measured with the Doppler-shift attenuation method using the 89 Y(p, nγ) 89 Zr reaction and observing the γ-rays in a Ge(Li) detector. The results are: τ (1628) = 370 ± 50fs, τ (1743) = 710 ± 180 fs, τ (1835) = 460 ± 190 fs, τ (2100) = 180 ± 60 fs, τ (2298) = 105 ± 30 fs, τ (2388)
R.D. Gill, J.M.G. Caraça, A.J. Cox, H.J. Rose   +3 more
openaire   +1 more source

Structure of the 89Zr via the high-resolution 91Zr(p,t)89Zr reaction and shell-model calculations

Nuclear Physics A, 2002
Abstract The 91 Zr(p, t) 89 Zr reaction has been studied in a high-resolution experiment at an incident proton energy of 25 MeV. Angular distributions for transitions to 44 levels of 89 Zr up to an excitation energy of ∼ 3.650 MeV have been measured.
P. Guazzoni, L. Zetta, J.N. Gu, A. Vitturi, Y. Eisermann, G. Graw, R. Hertenberger, M. Jaskola   +7 more
openaire   +1 more source